ClinicalTrials.Veeva

Menu

Retinal Pigment Epithelium Safety Study for Patients in B4711001

M

Moorfields Eye Hospital NHS Foundation Trust

Status

Active, not recruiting

Conditions

Age Related Macular Degeneration

Study type

Observational

Funder types

Other

Identifiers

NCT03102138
2015-002267-42 (EudraCT Number)
DACL1013

Details and patient eligibility

About

This is a safety follow-up study. Patients enrolled in B4711001 will be followed for a further 4 years with regular visits to assess safety.

Enrollment

10 estimated patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Evidence of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study.
  • Previous participation in Protocol B4711001 and received treatment with PF-05206388.
  • Subjects who are willing and able to comply with scheduled visits, and study procedures.

Exclusion criteria

  • there are no exclusion criteria

Trial design

10 participants in 1 patient group

observation
Description:
subjects treated in B4711001 with PF-05206388 will be assessed

Trial contacts and locations

1

Loading...

Central trial contact

Declan Flanagan

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems